Awards & Recognition
Awards & Recognition
HOPA Award of Excellence
The HOPA Award of Excellence recognizes a HOPA member who has made a significant, sustained contribution to or provided excellent leadership in developing or supporting hematology/oncology pharmacy.
2019 George Carro, RPh MS BCOP
2018 R. Donald Harvey, PharmD BCOP FCCP FHOPA
2017 Terri G. Davidson, PharmD BCCP BCOP FASHP
2016 Niesha L. Griffith, MS RPh FASHP
2015 David W. Henry, MS BCOP FASHP
2014 Rowena N. Schwartz, PharmD BCOP
2013 Robert Ignoffo, PharmD FASHP FCSHP
2012 Susan Goodin, PharmD
2011 Jim Koeller, MS
2010 Val R. Adams, PharmD FCCP BCOP
2009 Barry R. Goldspiel, PharmD BCOP BCPS FASHP FISOPP
2008 Carol M. Balmer, PharmD BCOP
2007 Jane M. Pruemer, PharmD BCOP FASHP
2006 Judy L. Chase, PharmD FASHP;
Amy W. Valley, PharmD BCOP
2005 LeAnne D. Kennedy, BCOP
HOPA Diversity, Equity, and Inclusion Award
2022 Maurice Alexander, PharmD, BCOP & Britny R. Brown, PharmD, BCOP
HOPA New Practitioner Award
The HOPA New Practitioner Award recognizes a HOPA member early in their career who has made a significant contribution to developing or supporting clinical hematology/oncology pharmacy services.
2022 Kathryn Maples, PharmD, BCOP
2021 Justin Arnall, PharmD, BCOP
2020 Kirollos S. Hanna, PharmD, BCPS, BCOP & Megan N. Dillaman, PharmD, BCOP
2019 Megan May, PharmD BCOP
2018 Alexandra Shillingburg, PharmD BCOP
2017 Amber Bradley Clemmons, PharmD BCOP
2016 Kristin Held Wheatley, PharmD BCOP
2015 Patrick J. Kiel, PharmD BCPS BCOP
2014 Robert S. Mancini, PharmD BCOP
2013 Steve Stricker, PharmD MS BCOP
2012 Daniel Zlott, PharmD BCOP
2011 Trevor McKibbin, PharmD MS BCPS
2010 LeAnn Best Norris, PharmD BCPS BCOP
2009 Julianna Burzynski, PharmD BCPS BCOP
2008 Janet Espirito, PharmD BCOP
HOPA Patient Advocacy Award
The HOPA Patient Advocacy Award recognizes a HOPA member who demonstrates leadership and collaboration while advocating for outstanding patient care.
2022 Sarah E. Wheeler, PharmD, BCOP
2021 Megan Langer, PharmD, BCOP
2020 Kathy Hogan Edwards, PharmD, BCPS, BCOP
2019 Ashley Glode, PharmD BCOP
2017 Kerry Parsons, PharmD BCOP FHOPA
2016 Benyam Muluneh, PharmD BCOP CPP
2015 Rowena N. Schwartz, PharmD BCOP
2014 Sarah S. Hudson-DiSalle, PharmD RPh
HOPA Technician Award
The HOPA Hematology/Oncology Technician Award recognizes a HOPA technician member who demonstrates excellence in his/her work and a commitment to hematology/oncology pharmacy practice in an organized healthcare setting.
2022 Alicia M. Holguin, CPhT & May Lo
2021 Emily Zimdars, BA, CPhT & Jessica Turner, CPhT
2020 Alexamil Rodriguez, CPhT
2019 Amanda Pate, CPhT
2018 Desiree Rolniak, CPhT
2017 Cheryl Hyk, MA CPhT
2016 Edward D. Gormley, BS CPhT
2011 Tanja Monroe
2010 Therese McGrain, CPhT
2009 Jeanne Anderson, CPhT
2008 Kenneth Grohgans, CPhT
2007 Darrell Clarke, CPhT;
Anne Hameed, CPhT
HOPA Volunteer Award
The HOPA Volunteer Award recognizes the time, talent and energy of a HOPA member who contributes significant volunteer service to the organization.
2022 Mallika P. Patel, PharmD, CPP
2020 Eve-Michell Segal, PharmD, BCOP
2019 Ila Saunders, PharmD BCOP
HOPA Leadership Award
The HOPA Leadership Award recognizes pharmacy practitioners who have distinguished themselves by demonstrating superior leadership skills when challenged by a specific opportunity, for their institution, HOPA, or the pharmacy profession that produced/culminated in a significant outcome. As a result they will have advanced oncology pharmacy practice, or made positive changes that benefit patients, students, or colleagues in hematology/oncology pharmacy.
2021 Ali McBride, PharmD, MS
HOPA Oncology Pharmacy Practice Literature Award
This award recognizes an author who has written an article, other than scientific research, that contributes significantly to the betterment of the hematology/oncology pharmacy profession and describes innovations in community, hospital, or healthcare system hematology/oncology pharmacy practices that are applicable beyond the practice site where they were developed and/or evaluated.
2022 Shannon Hough, PharmD, BCOP
Hough S, McDevitt R, Nachar VR, Kraft S, Brown A, Christen C, Frame D, Smerage JB. Chemotherapy Remote Care Monitoring Program: Integration of SMS Text Patient-Reported Outcomes in the Electronic Health Record and Pharmacist Intervention for Chemotherapy-Induced Nausea and Vomiting. JCO Oncol Pract. 2021 Feb 3:OP2000639. doi: 10.1200/OP.20.00639
2021 Grant Lee, PharmD
Lee GW, Mathur AD, Andrick BJ, Leese E, Zally D, Gatson NTN. Pharmacist value-added to neuro-oncology subspecialty clinics: a pilot study uncovers opportunities for best practices and optimal time utilization. J Oncol Pharm Pract. 2020 Sep 17;1078155220957738. PubMed PMID: 32938297.
2020 Jacqueline L. Olin, M.S., PharmD, BCPS
Olin JL, Klibanov O, Chan A, Spooner LM. Managing pharmacotherapy in people living with HIV and concomitant malignancy. Ann Pharmacother 2019 Aug;53(8):812-832. doi: 10.1177/1060028019833038. Epub 2019 Feb 15.
2019 Julianne Orr, PharmD BCOP
Clemmons AB, Orr J, Andrick B, Gandhi A, Sportes C, Deremer D. Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O Trial. Biology of Blood and Marrow Transplantation. 2018;24(10):2065–71.
2017 Karen Sweiss, PharmD
Sweiss K, Patel S, Culos K, Oh A, Rondelli D, Patel P. Melphalan 200 mg/m2 in patients with renal impairment is associated with increased short term toxicity but improved response and longer treatment-free survival. Bone Marrow Transplant 2016; e-pub ahead of print 16 May 2016; doi:10.1038/bmt.2016.136.
2016 Ginah Nightingale, PharmD BCOP
Nightingale G, Hajjar E, Swartz K, et al. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J Clin Oncol. 2015;33:1453-1459.
2015 Joseph S. Bubalo, PharmD BCOP BCPS
Bubalo J, Carpenter PA, Majhail N, Perales MA, Marks DI, Shaughnessy P, Pidala J, Leather HL, Wingard J, Savani BN. Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee. Biol Blood Marrow Transplant. 2014 May;20(5):600-16. doi:10.1016/j.bbmt.2014.01.019. Epub 2014 Jan 23.
2014 Ali McBride, PharmD MS BCPS BCOP
McBride A, Lathon S, Boehmer L, Augustin KM, Butler SK, Westervelt P. Comparative Evaluation of Single Fixed Dosing and Weight-Based Dosing of Rasburicase for Tumor Lysis Syndrome. Pharmacotherapy. 2013;33(3):295-303.
2013 Kamakshi V. Rao, PharmD BCOP CPP
Strother RM, Rao KV, Gregory KM, Jakait B, Busakhala N, Schellhase E, Pastakia S, Krzyzanowski M, Loehrer PJ. The oncology pharmacy in cancer care delivery in a resource-constrained setting in western Kenya. J Oncol Pharm Pract 2012. Jan 16
2012 Kristine R. Crews, PharmD, BCPS
Crews KR, Cross SJ, McCormick JN, Baker DK, Molinelli AR, Mullins R, Relling MV, Hoffman JM. Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health Syst Pharm 68:143-50, 2011
2010 Brian Crandell, PharmD, BCOP
O'Bryant CL, Crandell BC. Community pharmacists’ knowledge of and attitudes toward oral chemotherapy. J Am Pharm Assoc. 2008;48:632-9.
HOPA Basic Science and Clinical Research Literature Award
This award recognizes an author who has written an important scientific article describing hematology/oncology basic science and/or translational research or clinical trials evaluating drug efficacy and/or safety.
2022 Lydia Benitez, PharmD, BCOP
Benitez LL, Perissinotti AJ, Rausch CR, Klaus J, Clark SM, Filtz M, Ratermann K, Treptow C, Griffin S, Olson M, Crain M, Kadia T, Pettit K, Burke PW, Bixby DL, Marini BL. Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia. Leuk Lymphoma. 2021 Apr 8:1-9. doi: 10.1080/10428194.2021.1907378. Epub ahead of print. PMID: 33830856.
2021 Victoria Nachar, PharmD, BCOP
Hoylman E, Brown A, Perissinotti A, et al. Optimal sequence of daratumumab and elotuzumab in relapsed and refractory multiple myeloma. Leuk Lymphoma. 2020 Mar;61(3):691-698
2020 Daniel J. Crona, PharmD, PhD, CPP
Crona DJ, Skol AD, Leppänen V-M, Glubb DM, Etheridge AS, Hilliard E, Peña C, Peterson Y, Klauber-DeMore N, Alitalo KK, Innocenti F. Novel genetic determinants of survival in renal cell carcinoma patients treated with sorafenib: a clinical and translational experimental study. Cancer Res. 2019 Jan; 79(1):231-241. PMCID: PMC6541205.
2019 Judith A. Smith, BS PharmD BCOP CPHQ FCCP FISOPP
Cotton S, Brown RE, Nugent EK, Robazetti SC, Berens PD, Smith JA. Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus Infections. Obstetrics & Gynecology. 2018Apr;131(4):681–7.
2016 Meghana V. Trivedi, PharmD PhD BCOP
Do T, Medhekar R, Bhat R, Chen H, Niravath P, Trivedi MV. The risk of febrile neutropenia and need for G-CSF primary prophylaxis with the docetaxel and cyclophosphamide regimen in early-stage breast cancer patients: a meta-analysis. Breast Cancer Res Treat. 2015 Oct;153(3):591-7. Epub 2015 Sep 4.
2015 David J. Reeves, PharmD BCOP
Reeves DJ, Moore ES, Bascom D, Rensing B. Retrospective evaluation of methotrexate elimination when co-administered with proton pump inhibitors. Br J Clin Pharmacol. 2014 Sep;78(3):565-71. Doi: 10.1111/bcp.12384 PMID: 24646036
2014 Casey B. Williams, PharmD BCOP
Williams CB, Kambhampati S, Fiskus W, Wick J, Dutreix C, Ganguly S, Aljitawi O, Reyes R, Fleming A, Abhyankar S, Bhalla KN, McGuirk JP. Preclinical and Phase I Results of Decitabine in Combination with Midostaurin (PKC412) for Newly Diagnosed Elderly or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia. Pharmacotherapy. 2013 Jun 24. doi: 10.1002/phar.1316.
2013 Wendelin Nelson, PharmD BCOP
Nelson WK, Formica RN, Cooper DL, Schwartz PE, Rutherford TJ. An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers. J Oncol Pharm Pract 2012;18(3):323-332.
2012 Cindy O'Bryant, PharmD BCOP FCCP
O'Bryant CL, Haluska P, Rosen L, Ramanathan RK, Venugopal B, Leong S, Boinpally R, Franke A, Witt K, Evans J, Belani C, Gail Eckhardt S, Ramalingam S. An open-label study to describe pharmacokinetic parameters of erlotinib in patients with advanced solid tumors with adequate and moderately impaired hepatic function. Cancer Chemother Pharmacol. 2011 Sep 22
2011 Jacob K. Kettle, PharmD
Kettle JK, Grauer D, Folker TL, et al. Effectiveness of exogenous albumin administration for the prevention of ifosfamide-induced encephalopathy. Pharmacotherapy. 2010;30(8):812-817.
2010 LeAnne Kennedy, PharmD, BCOP
Kennedy LD, Case LD, Hurd DD, Cruz JM, Pomper GJ. A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions. Transfusion. 2008;48:2285-91.
HOPA Clinical Practice Literature Award
2009 Stacy S. Shord, PharmD, BCOP
Sandra Cuellar, PharmD, BCOP
Shord SS, Hamilton JM Jr, Cuellar S. Parenteral iron with erythropoiesis-stimulating agents for chemotherapy-induced anemia. J Oncol Pharm Pract. 2008;14:5-22.
2007 Donald A. Hutcherson, RPh
Hutcherson DA, Gammon DC, Bhatt MS, Faneuf M. Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy. Pharmacotherapy. 2006;26:242-247.
2006 Susan Goodin, PharmD, BCOP
Blower P, de Wit R, Goodin S, Aapro M. Drug-drug interactions in oncology: Why are they important and can they be minimized? Crit Rev Oncol Hematol. 2005;55:117-142
HOPA Clinical Practice Award
The HOPA Clinical Practice Award recognizes a HOPA member who has made a significant contribution to or has provided leadership to developing or supporting an innovative clinical hematology/oncology pharmacy service.
2007 Dominic A. Solimando Jr, MA, RPh, BCOP, FAPhA, FASHP
2006 David Baribeault, RPh, BCOP
Sachin Shah, PharmD, BCOP